Here at Teva, our Global Specialty Medicines business has a world-leading position in innovative treatments for disorders of the central nervous system (CNS), including neurological and neurodegenerative diseases, pain, psychiatry and movement disorders, as well as a strong portfolio of products to address respiratory disease, including asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD). Our innovative drug development efforts span both small molecules and biologics. We further integrate our generics and specialty capabilities in our global research and development (R&D) division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services, analytics and technologies.
Early Stage Clinical Development
In order to refocus our approach to organic, innovative R&D, so as to be centered on patients’ characteristics, needs and preferences from early stages of discovery, we have formed the Early Stage Clinical Development (ESCD) unit within the Chief Medical Officer’s organization. This is a crucial element in our growth strategy, integrating innovation, simplification, capability alignment, expert execution and above all increasing the probability of success to address meaningful clinical needs that improve patients’ and care-givers’ lives. Ultimately, harnessing patient and clinical insights to guide the scientific and technical expertise embedded in pre-clinical and clinical R&D stages is expected to optimize candidate selection towards favorable and competitive risk-benefit profiles. To this end, ESCD integrates key functions that collaborate closely with both discovery engines and physician leads: Clinical Pharmacology and Pharmacometrics; Personalized and Predictive Medicine; Translational Development; Analytics and Big Data; and the Clinical Development Patient Officer.
Clinical Development Patient Officer
Within ESCD, a core function newly embedded into R&D processes pre-registration, is the Clinical Development Patient Officer. This role will bridge the gap between traditional development efforts and input from patients and caregivers on their needs and preferences as affecting the chemistry of drug candidates, the selection of biomarkers and digital markers, as well as the design of clinical trials. It is envisages that by embedding this contribution earlier in the R&D process Teva will more effectively tailor pharmaceutical solutions to medical needs. The Patient Officer will identify patients and care-giver stakeholders in each of our core R&D therapeutic areas to incorporate their involvement along development efforts and decision making processes. The successful candidate will translate what is heard and understood from the patient into valuable insights affecting our product development cycles, devices and programs. These activities will require intimate integration into discovery and drug development activities and will not include post-marketing engagement activities. .
The Patient Officer will report directly to the Head of Early Stage Clinical Development and serve as ambassador of innovative, patient-centric drug development to foster patient impact on discovery and clinical development.
Utilize innovative and systematic approaches to patient and caregiver involvement by way of identifying appropriate contacts and facilitating actionable discussions at relevant cross-functional forums and decision gates.
Harness multiple resources to cover unmet needs and preferences across geographies, regulatory jurisdictions and cultures (eg FDA and EMA’s Patient Advocacy Initiatives which document patients’ and families’ perspectives on benefits and risks as they relate to drug development and regulatory decision making).
Develop compelling vision and strategy to improve patient focused drug development and outcomes.
Set the stage and create framework for patient centricity thinking and understanding at all levels within the organization
Identify key obstacles impacting the patient experience and present to leadership with action items and results-driven approach. As a consequence, effectively articulate challenges, be proactive in constructing new processes; monitor, execute and facilitate change
Invoke enthusiasm for new initiatives, garner the necessary commitment from stakeholders and team members
Shape and launch educational and training programs throughout the organization focused on patient input into trial design initiatives
Stay current on evolving needs and priorities of patients and families and adjusting trajectory, at all stages, accordingly
Lead, influence and inspire across the organization
Share successes; fail fast, learn from failures
We seek candidates with the following qualifications:
-At least 5 years of experience in either patient-related drug development activities, or patient-related academic/medical research/care
-Experience with organizational change management
-Highly organized and able to prioritize and handle multiple tasks simultaneously
-Possess a patient centric mindset; committed to adding value to a high quality clinical trial system that is patient efficient, enabling reliable therapeutic prevention and treatment.
-Accomplished at improving processes
-Demonstrates resilience and persistence
-Experience interacting with regulatory agencies or lobby groups is an advantage
-Proves to be an innovative thinker ensuing in transformations; challenges the status quo
-Being outspoken, eloquent and able to translate experiences and feelings into actionable and discrete therapeutic requirements
-Positive attitude and belief in the pharmaceutical industry as developers of life improving and life-saving solutions for patients and their families
-Position can be based in Great Valley, Pennsylvania or Netanya, Israel